Pseudobulbar Affect in Parkinsonian Disorders: A Review

被引:12
|
作者
Hakimi, Mathew [1 ]
Maurer, Carine W. [2 ]
机构
[1] SUNY Stony Brook, Sch Med, Stony Brook, NY 11794 USA
[2] SUNY Stony Brook, Sch Med, Dept Neurol, Stony Brook, NY 11794 USA
关键词
Pseudobulbar affect; Parkinson's disease; parkinsonism; PATHOLOGICAL LAUGHTER; DEXTROMETHORPHAN/QUINIDINE; STIMULATION; VALIDATION; FREQUENCY; QUINIDINE; DISEASE; REGION; SCALE; MOOD;
D O I
10.14802/jmd.18051
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Pseudobulbar affect (PBA) is a neurological symptom of inappropriate and uncontrollable laughter or crying that occurs secondary to a variety of neurological conditions, including parkinsonian disorders. PBA is a socially and emotionally debilitating symptom that has been estimated to affect 3.6% to 42.5% of the population with Parkinson's disease. While indexing measures and treatment options for PBA have been extensively studied in neurological conditions such as amyotrophic lateral sclerosis and multiple sclerosis, there has been considerably less attention given in the literature to PBA in parkinsonian disorders. The purpose of this review is to discuss the pathophysiology of PBA, its prevalence and impact on quality of life in parkinsonian disorders, and the treatment options currently available. Areas requiring further study, including the development of standardized, cross-culturally validated methods of symptom assessment, and evidence-based studies exploring the efficacy of current treatment options in parkinsonian disorders, are also highlighted.
引用
收藏
页码:14 / 21
页数:8
相关论文
共 50 条
  • [21] Dextromethorphan/QuinidineIn Pseudobulbar Affect
    Karly P. Garnock-Jones
    CNS Drugs, 2011, 25 : 435 - 445
  • [22] NueDexta: A Treatment for Pseudobulbar Affect
    Roman, Marian W.
    ISSUES IN MENTAL HEALTH NURSING, 2015, 36 (12) : 1019 - 1021
  • [23] Measuring pseudobulbar affect in ALS
    Smith, RA
    Berg, JE
    Pope, LE
    Thisted, RA
    AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS, 2004, 5 : 99 - 102
  • [24] Pseudobulbar affect in patients with stroke
    Constanza Segamarchi, Maria
    Alet, Matias
    Claverie, Santiago
    Lepera, Sandra
    Adrian Gonzalez, Leonardo
    Rey, Raul
    NEUROLOGY, 2019, 92 (15)
  • [25] Pharmacotherapeutic Management of Pseudobulbar Affect
    Chen, Jack J.
    AMERICAN JOURNAL OF MANAGED CARE, 2017, 23 (18): : S345 - S350
  • [26] Pseudobulbar affect: prevalence and management
    Ahmed, Aiesha
    Simmons, Zachary
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2013, 9 : 483 - 489
  • [27] Dextromethorphan/Quinidine In Pseudobulbar Affect
    Garnock-Jones, Karly P.
    CNS DRUGS, 2011, 25 (05) : 435 - 445
  • [28] Impact of pseudobulbar affect on caregivers
    Wynn, Daniel
    Kaye, Randall
    Hepner, Adrian
    Arnold, Ryan
    ANNALS OF NEUROLOGY, 2008, 64 : S39 - S39
  • [29] Pseudobulbar Affect Presenting as Hypomania
    Espiridion, Eduardo D.
    Mitchell, Cassandra
    Kadakia, Shreeja
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (03)
  • [30] SEROTONIN, FLUOXETINE, AND PSEUDOBULBAR AFFECT
    SELIGER, GM
    HORNSTEIN, A
    NEUROLOGY, 1989, 39 (10) : 1400 - 1400